Merck (MRK) reported Q2 FY 2020 earnings of $1.37 per share (versus $1.30 per share in Q2 FY 2019), beating analysts’ consensus estimate of $1.05 per share.
The company’s quarterly revenues amounted to $10.872 bln (-7.6% y/y), beating analysts’ consensus estimate of $10.524 bln.
MRK rose to $81.20 (+2.80%) in pre-market trading.